IAP104 - Assessment of Pharmacokinetic Changes Following Concurrent Administration of Sufentanil NanoTab and Ketoconazole in Healthy Subjects
Latest Information Update: 05 Mar 2024
At a glance
- Drugs Sufentanil (Primary) ; Ketoconazole
- Indications Acute pain; Cancer pain; Postoperative pain
- Focus Pharmacokinetics
- Sponsors AcelRx Pharmaceuticals; Talphera
- 09 Jan 2024 According to Talphera media release, AcelRx Pharmaceuticals changed its name to Talphera, Inc.
- 31 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.